Company Overview
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
Why Investors Should Care
Revenue has grown at a 13.1% CAGR over the past five years.
Recent Developments
- Jun 2025 Revenue of $110.46K (-33.8% YoY); net profit $-3.62M.
- Trailing 12 Months Year-on-year growth — revenue +171.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.08% |
| 1 Year: | 171.50% |
Stock Price Performance
| 1 Year: | -62.68% |
| 6 Months: | -41.11% |
| 3 Months: | -15.20% |
| 1 Month: | +0.95% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)51.16 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.1% over 5 years.
CONS
- Trading 72.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AMST Amesite Inc. TECH | 1.06 | -1.68 | $6.94M | 0.00% | -131.59% | -121.49% | 13.08% | - |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Dec 2019 | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.70K | 32.61K | 20.94K | 110.11K | 106.81K | 201.39K | 140.69K | 189.17K | 209.52K | 280.28K | 237.14K | 204.59K | 63.33K | 41.44K | 34.26K | 11.25K | 12.76K | 30.69K | 94.30K | 108.05K | 83.33K |
| Operating Income | - | - | - | - | - | - | - | -2.33M | -2.21M | -1.58M | -711.99K | -945.48K | -949.99K | -956.08K | -1.46M | -927.34K | -1.13M | -687.72K | -662.12K | -745.25K | -684.07K |
| Net Income | -953.10K | -959.65K | -876.68K | -5.09M | -2.29M | -2.32M | -2.38M | -2.32M | -2.22M | -1.58M | -699.48K | -928.00K | -890.69K | -905.61K | -1.43M | -908.04K | -1.12M | -663.42K | -642.27K | -732.55K | -678.06K |
| Diluted EPS | - | - | - | - | - | - | -0.11 | -0.11 | -1.12 | -0.69 | -0.28 | -0.37 | -0.35 | -0.36 | -0.56 | -0.34 | -0.40 | -0.16 | -0.14 | -0.16 | -0.15 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | 333.43K | 331.22K | 223.84K | 139.66K | 211.87K | 172.10K | 102.89K | 164.85K | 134.19K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Revenue | 59.75K | 674.58K | 697.00K | 845.01K | 166.88K | 110.46K |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 9.75M | 5.07M | 4.75M | 3.71M |
| Operating Income | - | - | -9.06M | -4.22M | -4.58M | -3.60M |
| EBITDA | - | - | -8.18M | -3.47M | -4.05M | -3.17M |
| Interest Expense | - | - | 12.63K | 1.62K | 0 | - |
| Pretax Income | - | - | -9.06M | -4.15M | -4.40M | -3.62M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | -4.17M | -11.59M | -9.06M | -4.15M | -4.40M | -3.62M |
| Diluted EPS | - | -0.59 | -4.67 | -1.68 | -1.73 | -1.03 |
| R&D Expense | - | - | 3.06M | 1.52M | 1.07M | 691.15K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 5.70M | 12.48M | 8.88M | 6.35M | 3.31M | 3.10M |
| Total Equity | 1.84M | 3.00M | 11.74M | 8.14M | 6.08M | 2.52M | 2.74M |
| Cash & Equivalents | 1.01M | 4.09M | 10.71M | - | 5.26M | 2.07M | 2.33M |
| Current Liabilities | - | 2.70M | 741.74K | 748.11K | 265.33K | 798.47K | 358.60K |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.81M | -5.33M | -6.72M | -3.25M | -2.81M | -2.46M |
| Investing Cash Flow | -795.75K | -842.33K | -711.62K | -396.03K | -375.87K | -378.30K |
| Financing Cash Flow | 6.69M | 12.80M | 3.87M | 1.85M | - | 3.10M |
| Capital Expenditure | -10.76K | -73.43K | -16.57K | -27.12K | -1.17K | - |
| Free Cash Flow | -2.82M | -5.41M | -6.73M | -3.28M | -2.81M | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | -1,299.4% | -499.9% | -2,744.3% | -3,262.4% |
| Net Margin % | -6,979.7% | -1,717.6% | -1,299.8% | -491.5% | -2,638.5% | -3,274.6% |
| ROE % | -139.0% | -98.7% | -111.4% | -68.3% | -175.0% | -132.1% |
| ROCE % | - | - | -111.3% | -69.4% | -182.0% | -131.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Focus Partners Wealth | 2.56% | 167.38K | $180.77K |
| 2 | Goldman Sachs Group Inc | 0.91% | 59.42K | $64.18K |
| 3 | Geode Capital Management, LLC | 0.50% | 32.68K | $35.30K |
| 4 | State Street Corporation | 0.48% | 31.59K | $34.12K |
| 5 | Vanguard Capital Management LLC | 0.46% | 30.20K | $32.62K |
| 6 | Warberg Asset Management LLC | 0.22% | 14.29K | $15.43K |
| 7 | Vanguard Fiduciary Trust Co | 0.21% | 13.76K | $14.86K |
| 8 | Jane Street Group, LLC | 0.19% | 12.76K | $13.78K |
| 9 | Renaissance Technologies, LLC | 0.15% | 10.10K | $10.91K |
| 10 | Osaic Holdings Inc. | 0.15% | 10.00K | $10.80K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMST
Amesite Stock Soars 150% on New Enterprise Deal. What to Know.
Amesite shares soar on a major healthcare AI contract. But there are ample reasons to avoid chasing the momentum in AMST shares today.
Amesite Rips 250% On Its Largest AI Healthcare Deployment
Amesite secured a new enterprise customer representing an approximately 2,700-patient census for NurseMagic AI documentation.
Amesite shares skyrocket after landing largest enterprise client to date (AMST)
NurseMagic platform selected for large-scale healthcare deploymentAmesite Inc. (NASDAQ:AMST) shares soared 190% in premarket trading Tuesday after the company announced it had secured its largest enterprise customer so far, covering approxi…
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute CareDETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ d…
Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules
$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrantsDETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ …
Amesite Announces Insider-Led Private Placement Priced at a Premium to Market
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements with certain of its officers…
AMST — Frequently Asked Questions
What is the current share price of Amesite Inc. (AMST)?
As of 2026-09-19 21:16 PDT, Amesite Inc. (AMST) trades at $1.06 on NasdaqCM. Its 52-week range is $0.79 to $3.87.
What is the market capitalisation of AMST?
Amesite Inc. (AMST) has a market capitalisation of $6.94M on NasdaqCM.
What is the P/E ratio of AMST?
AMST trades at a trailing price-to-earnings (P/E) ratio of -1.68. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 3.93.
What is the return on equity (ROE) of AMST?
AMST has a return on equity (ROE) of -121.49%. Its return on capital employed (ROCE) is -131.59%.
Is AMST a good stock to buy?
This page provides a data-driven analysis of Amesite Inc. (AMST), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.